George Elston appointed CFO, corporate development chief of EyePoint Pharmaceuticals

Specialty biopharmaceutical company EyePoint Pharmaceuticals appointed George O. Elston as CFO and head of corporate development.

Mr. Elston has been a consultant to the company and previously was the chief financial officer and head of corporate development for Enzyvant Therapeutics. At EyePoint, Mr. Elston will be responsible for the company's corporate development initiatives and financial markets. He has more than 25 years of senior and financial leadership in the biopharmaceutical industry.

"EyePoint is delighted to welcome George during this exciting period of momentum for our ongoing commercial launches of Dexycu and Yutiq in the U.S.,” said Nancy Lurker, president and CEO of EyePoint.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast